Statement of Changes in Beneficial Ownership (4)
August 25 2021 - 4:56PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Kaushal Nitin |
2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC.
[
VMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
625 E. KALISTE SALOOM RD. |
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/23/2021 |
(Street)
LAFAYETTE, LA 70508
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Restricted Stock Units | $0.0 (1) | 8/23/2021 | | A | | 13178 | | (2) | (2) | Common Shares | 13178.0 | $0 | 13178 | D | |
Explanation of Responses: |
(1) | Each Restricted Stock Unit (RSU) represents the right to receive one common share with respect to the date that the RSU vests, unless deferred at the election of the reporting person. The reporting person may elect to defer delivery of the common shares until the earlier to occur of (i) 60 days following the date that the reporting person separates from service with the Issuer and (ii) a specified date not to exceed 10 years from the date of grant of the Restricted Stock Units. |
(2) | On August 23, 2021, the reporting person was granted Restricted Stock Units which vest on August 23, 2022. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Kaushal Nitin 625 E. KALISTE SALOOM RD. LAFAYETTE, LA 70508 | X |
|
|
|
Signatures
|
/s/ Nitin Kaushal | | 8/24/2021 |
**Signature of Reporting Person | Date |
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Sep 2023 to Sep 2024